
Reviving Hope: Breakthrough Treatment Restores Sense of Smell in Long COVID Patients
A minimally invasive treatment using CT-guided stellate ganglion block is showing promise in restoring the sense of smell in long-COVID patients with parosmia. Early results from a study involving 54 patients indicate significant symptom improvement, with some patients experiencing near 100% resolution of symptoms. The treatment involves injecting anesthetic directly into the stellate ganglion on one side of the neck to stimulate the autonomic nervous system. Follow-up data showed a mean 49% improvement in symptoms at three months. The treatment has the potential to be a breakthrough in addressing the long-lasting effects of COVID-19 on the sense of smell.

